Published Date : Jan 07, 2016
The market segment of oral contraceptive pills in the pharmaceutical industry is gearing to exhibit an exponential growth in the near future. The latest market studies published reveal promising growth prospects for the niche is very promising particularly due to the rising awareness about the pregnancy preventive methods, their corresponding benefits, and favorable reimbursement policies introduced by the policy makers.
Among the most prominent brands available in the market Loestrin and Bayer’s Yaz have emerged as the most preferred ones in the category of 24-day pack. Seasonique by Teva Pharmaceutical Industries and Seasonale by Barr Laboratories are the preferred brands in the category of 91-day pack. Natazia by Bayer dominates the oral contraceptive market in the sub-segment of four-phase regimen.
Lately, the demand for emergency contraceptive pills is also surging to prevent pregnancy after unprotected sex. This treatment method however, is use only for specific conditions and should not be considered as one of the regular methods of birth control. To capitalize on this section of the market Teva Pharmaceuticals has introduced “Plan B One-Step”, which is an emergency contraceptive available without prescription over-the-counter without any age restrictions. Studies say that consumption of Plan B One-Step as per the direction prescribed reduces the chances of pregnancy by as much as 90%.
Likewise, the demand for oral contraceptive pills is also growing at a rapid pace, which can be attributed to the rising awareness about the advantages offered by contraceptives in preventing pregnancy. Due to the favorable reimbursement policies observed across the developed economies of North America, the region has emerged as the most lucrative market for oral contraceptive pills. Furthermore, North America witnesses a high incidence of unintended pregnancies, which significantly spurs the demand for oral contraceptive pills. According to a survey conducted by the Center of Disease Control and Prevention for the between 2006 and 2010, almost 37% of the pregnancies in the U.S. were unintended. Therefore, with an intent to curb such redundant healthcare spending, the governments across countries such as India, Norway, Sweden, and the U.S. are encouraging women to choose modern contraceptive pills as a more effective option of preventing unwanted pregnancy.